Kolexia
Terret Catherine Oncologie médicale
Terret Catherine
Oncologie médicale
Centre Léon-Bérard
Lyon, France
90 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Lymphome malin non hodgkinien Tumeurs colorectales Lymphomes Adénocarcinome Mélanome Métastase tumorale Leucémie aigüe myéloïde Tumeurs hématologiques

Collaborateurs

Voir plus
Cassier Philippe
Cassier Philippe
Centre Léon-Bérard, Lyon, France
Albrand Gilles
Albrand Gilles
Hôpital Lyon Sud, Pierre-Bénite, France
Eberst Lauriane
Eberst Lauriane
Hus Site Icans, Strasbourg, France
Perol David
Perol David
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Lilly
6 collaboration(s)
Dernière en 2023
MundiPharma
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Patients' selection and trial matching in early-phase oncology clinical trials.
Critical reviews in oncology/hematology   23 février 2024
Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   08 février 2024
GrannyFit: Digital Phenotyping (Physical Activity, Sleep) in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment
Essai Clinique (Institut Curie)   26 janvier 2024
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Science translational medicine   24 janvier 2024
AMPHISARC: A Multicenter, Phase I/II Study Evaluating the Clinical Impact of HDM201 + Pazopanib in Patients With P53 Wild-type Advanced/ Metastatic Soft Tissue Sarcomas (AMPHISARC)
Essai Clinique (Centre Léon-Bérard)   06 décembre 2023
703P Prognostic scores for immunotherapy-based phase one trials (P1T): To GRIm or not to GRIm?
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
OCAPI: An Interventional Prospective Study to Test the Feasibility of an Individualized Physical Activity Program in Patients Over 65 Years of Age With Hematologic Malignancies: the OCAPI Project.
Essai Clinique (Centre Léon-Bérard)   29 août 2023
Geriatric Assessment Implementation before Chemotherapy in MEtastatic Prostate Cancer, Results from the Real-Life Study GAMERS.
Journal of clinical medicine   18 février 2023
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis.
International journal of clinical oncology   16 janvier 2023
480P CATRIPCA – A phase I of pembrolizumab (P) combined with Xevinapant (Debio 1143, (X)) in patients (pts) with non MSI-high advanced/metastatic pancreatic ductal adenocarcinoma (PDAC) or colorectal cancer (CRC)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022